ASP2151
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for ASP2151, covering 2013-02-28 to 2024-10-09. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Study of ASP2151 in Herpes Simplex Patients [Phase 3]